Paper
0
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Authors
Won Ho,Qingfeng Zhu
Jennifer Durham,Aleksandra Popović,Stephanie Xavier,James Leatherman,Aditya Mohan,Guanglan Mo,Shu Zhang,Nicole Groß,Soren Charmsaz,Dongxia Lin,Derek Quong,Brad Wilt,Ihab Kamel,Matthew Weiss,Benjamin Philosophe,Richard Burkhart,William Burns,Chris Shubert,Aslam Ejaz,Jin He,Atul Deshpande,Ludmila Danilova,Genevieve Stein-O’Brien,Elizabeth Sugar,Daniel Laheru,Robert Anders,Elana Fertig,Elizabeth Jaffee
+28 authors
,Mark YarchoanJournal
Published
Jul 29, 2021
Show more
Save
Tip0
TipSave